NCT07816354

Brief Summary

This study aims to evaluate whether an MBI improves sleep quality, emotional symptoms (depression, anxiety, stress), emotion regulation, and trait mindfulness among adults with ESRD on HD. A randomized two-arm pre-post design was conducted with N = 38 patients at Dr. Soliman Fakeeh Hospital (DSFH), Saudi Arabia (n = 19 intervention; n = 19 control). The intervention comprised 30-minute guided sessions, 3 times a week for 5 weeks during HD sessions. The control group received the study intervention after the study. Outcomes were assessed at baseline and post-intervention using the Pittsburgh Sleep Quality Index (PSQI), Depression Anxiety Stress Scale-21 (DASS-21), Emotion Regulation Questionnaire (ERQ), and Mindful Attention Awareness Scale (MAAS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2025

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

September 7, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 11, 2026

Completed
Last Updated

September 11, 2026

Status Verified

September 1, 2026

Enrollment Period

7 months

First QC Date

September 7, 2026

Last Update Submit

September 7, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pittsburgh Sleep Quality Index

    It is used to gain a broad understanding of sleep architecture over the previous 30 days. This 19-item self-report questionnaire assesses seven components of sleep: sleep quality; sleep latency (time to fall asleep); sleep duration; sleep efficiency (time asleep, relative to total time in bed); sleep disturbances; use of sleeping medication; and daytime dysfunction (Buysse et al., 1989). The score for each component ranges from 0 to 3. Added together, the scores of the seven components produce a Global Sleep Quality Score, ranging from 0 to 21.

    From enrollment to the end of intervention at 5 weeks

  • Depression, Anxiety, and Stress Scale (DASS-21)

    The DASS-21 was used to assess the psychological distress of having end-stage renal disease. This scale includes three 7-item subscales that distinguish between the key elements of depression (e.g., dysphoria, hopelessness), anxiety (e.g., autonomic arousal, skeletal muscle effects) and stress (e.g., irritability, impatience). Respondents are asked to respond on a 4-point Likert scale according to how they have felt in the last week. As a shortened form of the original 42-item DASS, the scores of each of the three DASS-21 subscales are doubled to reflect ratings for the standard severity levels (from "Normal" to "Extremely Severe")

    From enrollment to the end of intervention at 5 weeks

Secondary Outcomes (2)

  • The Emotion Regulation Questionnaire (ERQ)

    From enrollment to the end of intervention at 5 weeks

  • Mindful Attention Awareness Scale (MAAS)

    From enrollment to the end of intervention at 5 weeks

Study Arms (2)

Mindfulness-based Intervention

EXPERIMENTAL

The intervention was a structured audio-based MBI program over a five-week period during regular hemodialysis procedure. The program, delivered using validated audio recordings, drew on the principles of mindfulness-based stress reduction (MBSR) and was tailored to the needs of hemodialysis patients. The intervention group participated in daily 30-minute sessions of guided MBI three times a week for five weeks. These sessions took place during the dialysis sessions to improve the feasibility and avoid placing further burdens on participants. The mindfulness intervention involved a number of key elements, such as focusing on the breathing, body scanning, awareness of the present moment and nonreactive monitoring of thoughts and feelings. Participants were advised to become mindful of their thoughts, feelings, and sensations, without trying to change them. The program also taught acceptance-based approaches and cognitive diffusion from negative thoughts.

Behavioral: Mindfulness-Based Intervention

Control Group

NO INTERVENTION

The control arm participants received no additional psychological or behavioural intervention during the trial

Interventions

The intervention was a structured audio-based MBI program over a five-week period during regular hemodialysis procedure. The program, delivered using validated audio recordings, drew on the principles of mindfulness-based stress reduction (MBSR) and was tailored to the needs of hemodialysis patients . The intervention group participated in daily 30-minute sessions of guided MBI three times a week for five weeks. These sessions took place during the dialysis sessions to improve the feasibility and avoid placing further burdens on participants. The mindfulness intervention involved a number of key elements, such as focusing on the breathing, body scanning, awareness of the present moment and nonreactive monitoring of thoughts and feelings. Participants were advised to become mindful of their thoughts, feelings, and sensations, without trying to change them. The program also taught acceptance-based approaches and cognitive diffusion from negative thought

Mindfulness-based Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being aged 18 or above
  • having a history of maintenance dialysis for three months
  • having the capacity to self-report

You may not qualify if:

  • Having acute psychiatric illness or substantial cognitive dysfunction
  • Involving in frequent meditation or yoga practice.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr. Sulima Fakeeh Hospital

Jeddah, Mecca Region, 23717, Saudi Arabia

Location

Related Publications (20)

  • Smith, J. C. 2005. Relaxation, Meditation, & Mindfulness: A Mental Health Practitioner's Guide to New and Traditional Approaches. Springer Publishing Company

    BACKGROUND
  • Rusch HL, Rosario M, Levison LM, Olivera A, Livingston WS, Wu T, Gill JM. The effect of mindfulness meditation on sleep quality: a systematic review and meta-analysis of randomized controlled trials. Ann N Y Acad Sci. 2019 Jun;1445(1):5-16. doi: 10.1111/nyas.13996. Epub 2018 Dec 21.

    PMID: 30575050BACKGROUND
  • Rigas, G., Kallergis, E. M., & Manios, E. (2022). Mindfulness-based interventions and psychological outcomes in chronic illness: A meta-analysis. Health Psychology Review, 16(3), 456-472. https://doi.org/10.1080/17437199.2021.1872375

    BACKGROUND
  • Razzera BN, Adamoli AN, Ranheiri MF, Oliveira MDS, Feoli AMP. Impacts of mindfulness-based interventions in people undergoing hemodialysis: a systematic review. J Bras Nefrol. 2022 Jan-Mar;44(1):84-96. doi: 10.1590/2175-8239-JBN-2021-0116.

    PMID: 34643641BACKGROUND
  • Rayan A, Ahmad M. The psychometric properties of the mindful attention awareness scale among Arab parents of children with autism spectrum disorder. Arch Psychiatr Nurs. 2018 Jun;32(3):444-448. doi: 10.1016/j.apnu.2018.01.001. Epub 2018 Jan 3.

    PMID: 29784228BACKGROUND
  • Nassim M, Park H, Dikaios E, Potes A, Elbaz S, Mc Veigh C, Lipman M, Novak M, Trinh E, Alam A, Suri RS, Thomas Z, Torres-Platas S, Vasudev A, Sasi N, Gautier M, Mucsi I, Noble H, Rej S. Brief Mindfulness Intervention vs. Health Enhancement Program for Patients Undergoing Dialysis: A Randomized Controlled Trial. Healthcare (Basel). 2021 Jun 1;9(6):659. doi: 10.3390/healthcare9060659.

    PMID: 34205915BACKGROUND
  • Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995 Mar;33(3):335-43. doi: 10.1016/0005-7967(94)00075-u.

    PMID: 7726811BACKGROUND
  • Keshky, M. E. E. (2018). Factor Structure, Reliability and Validity of the Arabic version of the Emotion Regulation Questionnaire (ERQ) in a sample of Saudi children and adolescents. International Journal of Psychology and Behavioral Sciences, 8(2), 22-30.

    BACKGROUND
  • Igarashi NS, Karam CH, Afonso RF, Carneiro FD, Lacerda SS, Santos BF, Kozasa EH, Rangel EB. The effects of a short-term meditation-based mindfulness protocol in patients receiving hemodialysis. Psychol Health Med. 2022 Jul;27(6):1286-1295. doi: 10.1080/13548506.2021.1871769. Epub 2021 Jan 15.

    PMID: 33449820BACKGROUND
  • Handayani, W., Yetti, K., Masfuri, M., & Yona, S. (2025). Application of mind-body therapies on anxiety and quality of life in patients undergoing hemodialysis: A systematic review. Malahayati International Journal of Nursing and Health Science, 8(1), 1-13.

    BACKGROUND
  • Gross JJ, John OP. Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being. J Pers Soc Psychol. 2003 Aug;85(2):348-62. doi: 10.1037/0022-3514.85.2.348.

    PMID: 12916575BACKGROUND
  • Gross JJ. Antecedent- and response-focused emotion regulation: divergent consequences for experience, expression, and physiology. J Pers Soc Psychol. 1998 Jan;74(1):224-37. doi: 10.1037//0022-3514.74.1.224.

    PMID: 9457784BACKGROUND
  • Garland EL, Hanley AW, Goldin PR, Gross JJ. Testing the mindfulness-to-meaning theory: Evidence for mindful positive emotion regulation from a reanalysis of longitudinal data. PLoS One. 2017 Dec 6;12(12):e0187727. doi: 10.1371/journal.pone.0187727. eCollection 2017.

    PMID: 29211754BACKGROUND
  • Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4.

    PMID: 2748771BACKGROUND
  • Brown KW, Ryan RM. The benefits of being present: mindfulness and its role in psychological well-being. J Pers Soc Psychol. 2003 Apr;84(4):822-48. doi: 10.1037/0022-3514.84.4.822.

    PMID: 12703651BACKGROUND
  • Alshammari, S. M., Shaheen, A. M., Alshammari, A. Z., & Hamdan-Mansour, A. M. (2025). Mindfulness meditation effects on sleep, stress, and physiological biomarkers in hemodialysis patients: A randomized controlled trial. Health Psychology Research. 13(3), e81240021. https://doi.org/10.14440/hpr.0186https://doi.org/10.14440/hpr.0186

    BACKGROUND
  • Almutary, H., Bonner, A., & Douglas, C. (2021). Symptom burden in chronic kidney disease: A systematic review. Journal of Renal Care, 47(1), 3-15. https://doi.org/10.1111/jorc.12334

    BACKGROUND
  • Almutary, H., Alghamdi, S., Mezan, A., Farsi, H., Alsayegh, A., Alqurashi, A., & Alharazi, R. (2025). Sleep quality and fatigue among hemodialysis patients. International Journal of Noncommunicable Diseases, 10(1), 33-40. https://doi.org/10.4103/jncd.jncd_114_24

    BACKGROUND
  • Alhawatmeh H, Najadat I, Hweidi I, Abuhammad S. The impact of mindfulness meditation on pro-inflammatory biomarkers in patients with end-stage renal disease: A randomized trial. SAGE Open Med. 2024 Dec 18;12:20503121241308995. doi: 10.1177/20503121241308995. eCollection 2024.

    PMID: 39713266BACKGROUND
  • Alhawatmeh H, Najadat IA, Hweidi IM. Mindfulness-based intervention as a symptom management strategy in patients with end-stage renal disease: A controlled clinical trial. Int J Nurs Pract. 2024 Dec;30(6):e13282. doi: 10.1111/ijn.13282. Epub 2024 Jun 16.

    PMID: 38880954BACKGROUND

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 7, 2026

First Posted

September 11, 2026

Study Start

January 1, 2025

Primary Completion

August 1, 2025

Study Completion

August 30, 2025

Last Updated

September 11, 2026

Record last verified: 2026-09

Locations